SAN DIEGO — New data confirmed the safety and efficacy of AXS-05, a combination of dextromethorphan and bupropion, for the treatment of agitation associated with Alzheimer’s disease (AD).

Official figures reveal referrals about criminal content have more than doubled in 12 months. Video / Mark Mitchell / Corey Fleming Alerts from Snapchat about predatory grooming and child sex ...